Researchers have identified special immune cells in the brain that help slow Alzheimer’s. These microglia work to reduce ...

Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgAN; ORIGIN Phase 3 trial met its primary endpoint at the prespecified interim analysis of proteinuri ...

Detailed price information for Allogene Therapeutics Inc (ALLO-Q) from The Globe and Mail including charting and trades.

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson's rashes, swelling, fevers, and severe pain for 6 years. She ...

Nektar Therapeutics today presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking oral abstract presentation at the American College of Allergy, Asthma & Immunology (ACAAI) ...

Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...

Low vitamin D might not directly cause depression, but maintaining healthy levels could still support better brain function ...

Bitter taste receptors inside cancer cells have been found to be activated in the presence of anti-cancer drugs. Shutting ...

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast ...

Hormonal imbalance is one of the most under-recognized drivers of modern chronic disease. Whether you're experiencing stress, ...